VieMed Healthcare ยท 14 hours ago
Senior Financial Planning & Analysis Analyst
VieMed Healthcare is seeking a Senior Financial Planning & Analysis Analyst to lead forecasting and financial modeling efforts. The role involves preparing performance dashboards, partnering with business units, and coaching junior analysts to optimize financial processes.
Health Care
Responsibilities
Own monthly and quarterly forecasting and projection models, incorporating business drivers and updated assumptions
Prepare and present monthly performance dashboards and variance analysis to department leaders and executives
Build dynamic financial models to evaluate business initiatives, cost structures, and financial performance
Partner with business units to understand trends, forecast accuracy, and areas for optimization
Support the establishment and reporting of KPIs that align with company strategy and department goals
Assist in implementing forecasting best practices and automation opportunities across FP&A
Coach and collaborate with junior analysts to build foundational modeling, budgeting, and analysis
Support the annual operating plan and multi-year strategic planning process
Drive continuous improvement in forecasting accuracy and decision support
Partner with Accounting on monthly and quarterly close activities
Support M&A efforts including financial modeling, diligence support, and post-acquisition budgeting
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or related field
3+ years of FP&A or financial modeling experience in a corporate environment, healthcare experience
Preferred
Proven experience with rolling forecasts, projection modeling, and scenario planning
Strong Excel and modeling capabilities
Experience with use of modern BI tools (Tableau, Power BI, MicroStrategy)
Excellent written and verbal communication skills
Ability to work independently, manage multiple priorities, and deliver on deadlines
Company
VieMed Healthcare
Viemed Healthcare provides equipment and home therapy to patients affected by specific respiratory diseases in the United States.
Funding
Current Stage
Public CompanyTotal Funding
unknown2017-12-22IPO
Recent News
2025-11-06
2025-11-06
2025-10-22
Company data provided by crunchbase